H.B. Coakham

Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.

Michael R. Zalutsky, R P Moseley, H.B. Coakham et al. · PubMed · 1989 · 152 citations

Medicine, Oncology, Pharmacology +15

Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry

Varnavas Papanastassiou, B. Pizer, H.B. Coakham et al. · British Journal of Cancer · 1993 · 66 citations · Full text

Medicine, Oncology, Pharmacokinetics +12

Treatment of neoplastic meningitis by targeted radiation using 131I-radiolabelled monoclonal antibodies

H.B. Coakham, John T. Kemshead · Journal of Neuro-Oncology · 1998 · 64 citations

Medicine, Nuclear Medicine, Oncology +17

Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel.

H.B. Coakham, Jeremy A. Garson, Patricia Allan et al. · Journal of Clinical Pathology · 1985 · 58 citations · Full text

Medicine, Oncology, Pathology +17

A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates

Kirsten Hopkins, C Chandler, J. Bullimore et al. · Radiotherapy and Oncology · 1995 · 55 citations

Medicine, Oncology, Radiation Oncology +16